CD163 and neoplasm: By employing single-cell analysis, we identified immunosuppressive LAMP3+ cDCs, likely promoting TREG migration into tumor tissues through the CCL17-CCR4 axis [47], in addition to increased CD163-positive macrophages previously associated with adverse TFHL prognoses [7, 14].